Compugen Stock

Compugen OCF/Debt

The Operating Cash Flow to Debt Ratio of Compugen (CGEN) as of Sep 7, 2026 is 148.70 %. In the previous year, Operating Cash Flow to Debt Ratio was 254.97 % — a change of -41.68% (lower).

OCF/Debt

148.70 %

YoY

-41.68%

Last updated:

Operating Cash Flow to Debt Ratio of Compugen is 2026 148.70 % . Operating Cash Flow to Debt Ratio of Compugen was 2025 254.97 % . It decreases by -41.68% lower compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Operating Cash Flow to Debt Ratio of Compugen is 148.70 % in 2026.

Operating Cash Flow to Debt Ratio of Compugen changed from 254.97 % to 148.70 %, representing a -41.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Compugen since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Compugen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Compugen

All Key Metrics — Compugen